Diamminodichloride platinum (cis-platinum) in the treatment of hepatocellular carcinoma.
D000293:Adolescent; D000328:Adult; D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000097:blood / Q000188:drug therapy*; D002945:Cisplatin / Q000009:adverse effects / Q000627:therapeutic use*; D004317:Doxorubicin / Q000627:therapeutic use; D005047:Etoposide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007677:Kidney Function Tests; D008113:Liver Neoplasms / Q000097:blood / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D013997:Time Factors; D014839:Vomiting / Q000139:chemically induced; D000509:alpha-Fetoproteins / Q000032:analysis
D000509:alpha-Fetoproteins; D005047:Etoposide; D004317:Doxorubicin; D002945:Cisplatin